279 related articles for article (PubMed ID: 10223577)
1. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.
Iyer RV; Hanlon AL; Pinover WH; Hanks GE
Cancer; 1999 Apr; 85(8):1816-21. PubMed ID: 10223577
[TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
[TBL] [Abstract][Full Text] [Related]
3. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.
Kaminski JM; Hanlon AL; Horwitz EM; Pinover WH; Mitra RK; Hanks GE
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):888-92. PubMed ID: 11958880
[TBL] [Abstract][Full Text] [Related]
4. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy.
Anderson PR; Hanlon AL; Patchefsky A; Al-Saleem T; Hanks GE
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1087-92. PubMed ID: 9719119
[TBL] [Abstract][Full Text] [Related]
5. Dose response in prostate cancer with 8-12 years' follow-up.
Hanks GE; Hanlon AL; Epstein B; Horwitz EM
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):427-35. PubMed ID: 12243818
[TBL] [Abstract][Full Text] [Related]
6. Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer.
Pinover WH; Hanlon AL; Horwitz EM; Hanks GE
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):649-54. PubMed ID: 10837947
[TBL] [Abstract][Full Text] [Related]
7. [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
Koh H; Maru N; Muramoto M; Wheeler TM; Scardino PT; Ohori M
Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):595-601. PubMed ID: 12174634
[TBL] [Abstract][Full Text] [Related]
8. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy.
Bonin SR; Hanlon AL; Lee WR; Movsas B; al-Saleem TI; Hanks GE
Cancer; 1997 Jan; 79(1):75-80. PubMed ID: 8988729
[TBL] [Abstract][Full Text] [Related]
9. Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy.
Anderson PR; Hanlon AL; Horwitz E; Pinover W; Hanks GE
Cancer; 2000 Dec; 89(12):2565-9. PubMed ID: 11135217
[TBL] [Abstract][Full Text] [Related]
10. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
11. Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate.
D'Amico AV; Desjardin A; Chen MH; Paik S; Schultz D; Renshaw AA; Loughlin KR; Richie JP
Cancer; 1998 Nov; 83(10):2172-80. PubMed ID: 9827722
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation.
Anderson PR; Hanlon AL; Movsas B; Hanks GE
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1025-30. PubMed ID: 9392540
[TBL] [Abstract][Full Text] [Related]
13. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
Zagars GK; Geara FB; Pollack A; von Eschenbach AC
Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
[TBL] [Abstract][Full Text] [Related]
14. The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.
Horwitz EM; Hanlon AL; Pinover WH; Hanks GE
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):519-23. PubMed ID: 9635697
[TBL] [Abstract][Full Text] [Related]
15. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.
Horwitz EM; Hanlon AL; Pinover WH; Anderson PR; Hanks GE
Cancer; 2001 Sep; 92(5):1281-7. PubMed ID: 11571744
[TBL] [Abstract][Full Text] [Related]
16. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
17. Positive prostate biopsy laterality and implications for staging.
Buyyounouski MK; Horwitz EM; Hanlon AL; Uzzo RG; Hanks GE; Pollack A
Urology; 2003 Aug; 62(2):298-303. PubMed ID: 12893339
[TBL] [Abstract][Full Text] [Related]
18. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
Han M; Walsh PC; Partin AW; Rodriguez R
J Urol; 2000 Jul; 164(1):89-92. PubMed ID: 10840430
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
20. The 1989 patterns of care study for prostate cancer: five-year outcomes.
Chuba PJ; Moughan J; Forman JD; Owen J; Hanks G
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):325-34. PubMed ID: 11380218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]